» Articles » PMID: 29497037

Rapid Measurement of Inhibitor Binding Kinetics by Isothermal Titration Calorimetry

Overview
Journal Nat Commun
Specialty Biology
Date 2018 Mar 3
PMID 29497037
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Although drug development typically focuses on binding thermodynamics, recent studies suggest that kinetic properties can strongly impact a drug candidate's efficacy. Robust techniques for measuring inhibitor association and dissociation rates are therefore essential. To address this need, we have developed a pair of complementary isothermal titration calorimetry (ITC) techniques for measuring the kinetics of enzyme inhibition. The advantages of ITC over standard techniques include speed, generality, and versatility; ITC also measures the rate of catalysis directly, making it ideal for quantifying rapid, inhibitor-dependent changes in enzyme activity. We used our methods to study the reversible covalent and non-covalent inhibitors of prolyl oligopeptidase (POP). We extracted kinetics spanning three orders of magnitude, including those too rapid for standard methods, and measured sub-nM binding affinities below the typical ITC limit. These results shed light on the inhibition of POP and demonstrate the general utility of ITC-based enzyme inhibition kinetic measurements.

Citing Articles

Rapid Determination of Kinetic Constants for Slow-Binding Inhibitors and Inactivators of Human Histone Deacetylase 8.

Kopranovic A, Meyer-Almes F Int J Mol Sci. 2024; 25(11).

PMID: 38891780 PMC: 11171933. DOI: 10.3390/ijms25115593.


Reply to Zarguan et al. Comment on "Budryn et al. Hydroxybenzoic Acids as Acetylcholinesterase Inhibitors: Calorimetric and Docking Simulation Studies. 2022, , 2476".

Grzelczyk J, Budryn G, Perez-Sanchez H Nutrients. 2022; 14(22).

PMID: 36432546 PMC: 9699467. DOI: 10.3390/nu14224860.


Bayesian regression and model selection for isothermal titration calorimetry with enantiomeric mixtures.

Nguyen T, La V, Burke K, Minh D PLoS One. 2022; 17(9):e0273656.

PMID: 36173969 PMC: 9521810. DOI: 10.1371/journal.pone.0273656.


The feasibility of determining kinetic constants from isothermal titration calorimetry data.

Tso S, Jowitt T, Brautigam C Biophys J. 2022; 121(12):2474-2484.

PMID: 35490299 PMC: 9279169. DOI: 10.1016/j.bpj.2022.04.035.


Disentangling the recognition complexity of a protein hub using a nanopore.

Mayse L, Imran A, Larimi M, Cosgrove M, Wolfe A, Movileanu L Nat Commun. 2022; 13(1):978.

PMID: 35190547 PMC: 8861093. DOI: 10.1038/s41467-022-28465-8.


References
1.
Tonge P . Drug-Target Kinetics in Drug Discovery. ACS Chem Neurosci. 2017; 9(1):29-39. PMC: 5767540. DOI: 10.1021/acschemneuro.7b00185. View

2.
Lawandi J, Gerber-Lemaire S, Juillerat-Jeanneret L, Moitessier N . Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors. J Med Chem. 2010; 53(9):3423-38. DOI: 10.1021/jm901104g. View

3.
Copeland R . The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety. Expert Opin Drug Discov. 2012; 5(4):305-10. DOI: 10.1517/17460441003677725. View

4.
Tanaka S, Suzuki K, Sakaguchi M . The prolyl oligopeptidase inhibitor SUAM-14746 attenuates the proliferation of human breast cancer cell lines in vitro. Breast Cancer. 2017; 24(5):658-666. DOI: 10.1007/s12282-017-0752-5. View

5.
De Cesco S, Kurian J, Dufresne C, Mittermaier A, Moitessier N . Covalent inhibitors design and discovery. Eur J Med Chem. 2017; 138:96-114. DOI: 10.1016/j.ejmech.2017.06.019. View